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Background
Next-generation sequencing technology is changing the
genomic research due to its huge sequencing capacity
which is used to identify rare susceptibility variants that
affect complex diseases. Because of its high cost, a two-
stage extreme phenotype sequencing (TS-EPS) design is
an alternative approach [1] in which the genetic variants
are discovered by whole-genome or whole-exome sequen-
cing individuals with extreme phenotypes in stage I and
the association variants are detected by sequencing a large
number of individuals on the discovered variants in stage
II. TS-EPS can efficiently discover more than half of the
causal variants using about 0.2% of all individuals [2] and
can therefore have higher power than random sampling
given the sample size and effect sizes of the causal variants
[2,3]. Using simulated data for unrelated individuals, we
further explore the efficiency of TS-ESP in term of differ-
ent sample sizes and varying effect sizes.
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Figure 1 Stage I SNP discovery results for independent SNPs based on 4 individuals with EP.
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Figure 2 Enrichment of causal SNPs in 4 individuals with EP.
Figure 3 Power of TS-EPS for independent SNPs based on 4 individuals at a nominal level of 5×10-5. OS: one-stage design; TS-ESP: two-stage
extreme phenotype sequencing design; OS-R: one-stage design exclude 4 individuals.
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Results
When four individuals with the first four most extreme
trait values are sequenced in stage I, we found that 1) TS-
EPS can discover the constant numbers of CVs, LCVs, and
RVs regardless of the sample size and effect size, however
the increasing numbers of causal variants with increasing
sample size and effect size (Figure 1); 2) the probability of
discovering a causal CV is constant regardless of its effect
sizes but the quantity depends on its minor allele fre-
quency; however, the probability of discovering RVs is a
complex function of their effect sizes and minor allele fre-
quencies given disease model and sample size (Figure 2).
3) Therefore, using an optimal unified association test for
gene-based association analyses, the power of TS-ESP is
comparable to one-stage (OS) design in which all indivi-
duals are sequenced for association testing if the rare
causal variants have large effect sizes (Figure 3).
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